BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 9153424)

  • 1. Mechanisms of stabilization of the insulin hexamer through allosteric ligand interactions.
    Rahuel-Clermont S; French CA; Kaarsholm NC; Dunn MF; Chou CI
    Biochemistry; 1997 May; 36(19):5837-45. PubMed ID: 9153424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carboxylate ions are strong allosteric ligands for the HisB10 sites of the R-state insulin hexamer.
    Huang ST; Choi WE; Bloom C; Leuenberger M; Dunn MF
    Biochemistry; 1997 Aug; 36(32):9878-88. PubMed ID: 9245420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ligand binding and thermostability of different allosteric states of the insulin zinc-hexamer.
    Huus K; Havelund S; Olsen HB; Sigurskjold BW; van de Weert M; Frokjaer S
    Biochemistry; 2006 Mar; 45(12):4014-24. PubMed ID: 16548529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural asymmetry and half-site reactivity in the T to R allosteric transition of the insulin hexamer.
    Brzović PS; Choi WE; Borchardt D; Kaarsholm NC; Dunn MF
    Biochemistry; 1994 Nov; 33(44):13057-69. PubMed ID: 7947711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of phenol to R6 insulin hexamers.
    Berchtold H; Hilgenfeld R
    Biopolymers; 1999; 51(2):165-72. PubMed ID: 10397800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zinc-ligand interactions modulate assembly and stability of the insulin hexamer -- a review.
    Dunn MF
    Biometals; 2005 Aug; 18(4):295-303. PubMed ID: 16158220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Half-site reactivity, negative cooperativity, and positive cooperativity: quantitative considerations of a plausible model.
    Bloom CR; Kaarsholm NC; Ha J; Dunn MF
    Biochemistry; 1997 Oct; 36(42):12759-65. PubMed ID: 9335532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin allosteric behavior: detection, identification, and quantification of allosteric states via 19F NMR.
    Bonaccio M; Ghaderi N; Borchardt D; Dunn MF
    Biochemistry; 2005 May; 44(21):7656-68. PubMed ID: 15909980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spectroscopic evidence for preexisting T- and R-state insulin hexamer conformations.
    Choi WE; Borchardt D; Kaarsholm NC; Brzovic PS; Dunn MF
    Proteins; 1996 Dec; 26(4):377-90. PubMed ID: 8990494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancing the T-->R transition of insulin by helix-promoting sequence modifications at the N-terminal B-chain.
    Shneine J; Voswinkel M; Federwisch M; Wollmer A
    Biol Chem; 2000 Feb; 381(2):127-33. PubMed ID: 10746744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The allosteric transition of the insulin hexamer is modulated by homotropic and heterotropic interactions.
    Choi WE; Brader ML; Aguilar V; Kaarsholm NC; Dunn MF
    Biochemistry; 1993 Nov; 32(43):11638-45. PubMed ID: 8218231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of metal ions in the T- to R-allosteric transition in the insulin hexamer.
    Kadima W
    Biochemistry; 1999 Oct; 38(41):13443-52. PubMed ID: 10521251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assembly and dissociation of human insulin and LysB28ProB29-insulin hexamers: a comparison study.
    Birnbaum DT; Kilcomons MA; DeFelippis MR; Beals JM
    Pharm Res; 1997 Jan; 14(1):25-36. PubMed ID: 9034217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure and dynamics of a protein assembly. 1H-NMR studies of the 36 kDa R6 insulin hexamer.
    Jacoby E; Hua QX; Stern AS; Frank BH; Weiss MA
    J Mol Biol; 1996 Apr; 258(1):136-57. PubMed ID: 8613983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the R-state insulin hexamer and its derivatives. The hexamer is stabilized by heterotropic ligand binding interactions.
    Brader ML; Kaarsholm NC; Lee RW; Dunn MF
    Biochemistry; 1991 Jul; 30(27):6636-45. PubMed ID: 2065051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of 2,6- and 2,7-dihydroxynaphthalene to wild-type and E-B13Q insulins: dynamic, equilibrium, and molecular modeling investigations.
    Bloom CR; Heymann R; Kaarsholm NC; Dunn MF
    Biochemistry; 1997 Oct; 36(42):12746-58. PubMed ID: 9335531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Raman signatures of ligand binding and allosteric conformation change in hexameric insulin.
    Ferrari D; Diers JR; Bocian DF; Kaarsholm NC; Dunn MF
    Biopolymers; 2001; 62(5):249-60. PubMed ID: 11745120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hierarchical modeling of phenolic ligand binding to 2Zn--insulin hexamers.
    Birnbaum DT; Dodd SW; Saxberg BE; Varshavsky AD; Beals JM
    Biochemistry; 1996 Apr; 35(17):5366-78. PubMed ID: 8611526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of solution structural flexibility and zinc binding domains for insulin, proinsulin, and miniproinsulin.
    Kaarsholm NC; Ko HC; Dunn MF
    Biochemistry; 1989 May; 28(10):4427-35. PubMed ID: 2669954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thermodynamic contributions to the stability of the insulin hexamer.
    Lisi GP; Png CY; Wilcox DE
    Biochemistry; 2014 Jun; 53(22):3576-84. PubMed ID: 24811232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.